Medicines on the FDA drug shortage list, with which forms and strengths are affected, who makes them and when supply is expected back.
240 medicines
-
Pilocarpine Hydrochloride Being discontinued 5 products · updated March 24, 2026
Ophthalmology
Product Availability Expected supply / notes Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-03)
AbbVie Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 24, 2026Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-05)
AbbVie Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 24, 2026Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04)
AbbVie Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 24, 2026Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-06)
AbbVie Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 24, 2026Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-01)
AbbVie Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 24, 2026 -
Pentamidine Isethionate Being discontinued 1 product · updated March 23, 2026
Anti-Infective
Product Availability Expected supply / notes Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2)
XGen Pharmaceuticals DJB, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · March 23, 2026 -
Ramelteon Being discontinued 2 products · updated March 19, 2026
Psychiatry
Product Availability Expected supply / notes Rozerem, Tablet, 8 mg (NDC 64764-805-30)
Takeda Pharmaceuticals USA Inc.Product is expected to be available through June 2027.
Being discontinued · March 19, 2026Rozerem, Tablet, 8 mg (NDC 64764-805-10)
Takeda Pharmaceuticals USA Inc.Product is expected to be available through February 2027.
Being discontinued · March 19, 2026 -
Plerixafor Being discontinued 1 product · updated March 13, 2026
Hematology
Product Availability Expected supply / notes Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)
Fresenius Kabi USA, LLCA business decision was made to discontinue manufacture of the drug.
Being discontinued · March 13, 2026 -
Peritoneal Dialysis Being discontinued 6 products · updated March 10, 2026
Renal
Product Availability Expected supply / notes DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2L, 5/cs (NDC 49230-209-92)
Fresenius Medical Care North AmericaThe NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
Being discontinued · March 10, 2026DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-209-94)
Fresenius Medical Care North AmericaThe NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
Being discontinued · March 10, 2026DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-206-94)
Fresenius Medical Care North AmericaThe NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
Being discontinued · March 10, 2026DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2L, 5/cs (NDC 46163-212-92)
Fresenius Medical Care North AmericaThe NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
Being discontinued · March 10, 2026DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 46163-212-94)
Fresenius Medical Care North AmericaThe NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
Being discontinued · March 10, 2026DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2L, 5/cs (NDC 46163-206-92)
Fresenius Medical Care North AmericaThe NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
Being discontinued · March 10, 2026 -
Itraconazole Being discontinued 3 products · updated February 27, 2026
Anti-Infective, Other
Product Availability Expected supply / notes Sporanox, Capsule, 100 mg (NDC 50458-290-01)
Janssen PharmaceuticalsDiscontinuation of the manufacture of the drug
Being discontinued · February 27, 2026Sporanox, Capsule, 100 mg (NDC 10147-1700-3)
Janssen PharmaceuticalsDiscontinuation of the manufacture of the drug
Being discontinued · February 27, 2026Sporanox, Capsule, 100 mg (NDC 50458-290-04)
Janssen PharmaceuticalsDiscontinuation of the manufacture of the drug
Being discontinued · February 27, 2026 -
Clindamycin Hydrochloride Being discontinued 3 products · updated February 25, 2026
Anti-Infective
Product Availability Expected supply / notes Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14)
Pfizer Inc.Discontinuation of the manufacture of the drug
Being discontinued · February 25, 2026Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02)
Pfizer Inc.Discontinuation of the manufacture of the drug
Being discontinued · February 25, 2026Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02)
Pfizer Inc.Discontinuation of the manufacture of the drug
Being discontinued · February 25, 2026 -
Frovatriptan Succinate Being discontinued 2 products · updated February 24, 2026
Neurology
Product Availability Expected supply / notes Frova, Tablet, 2.5 mg (NDC 63481-025-09)
Endo Pharmaceuticals, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · February 24, 2026Frova, Tablet, 2.5 mg (NDC 0603-3718-34)
Endo Pharmaceuticals, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · November 12, 2025 -
Irinotecan Hydrochloride Being discontinued 2 products · updated February 24, 2026
Oncology
Product Availability Expected supply / notes Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02)
Ingenus Pharmaceuticals LLCA business decision was made to discontinue manufacture of the drug.
Being discontinued · February 24, 2026Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05)
Ingenus Pharmaceuticals LLCA business decision was made to discontinue manufacture of the drug.
Being discontinued · February 24, 2026 -
Decitabine Being discontinued 2 products · updated February 20, 2026
Oncology
Product Availability Expected supply / notes Decitabine, Injection, 50 mg (NDC 68001-573-41)
Ingenus Pharmaceuticals LLCLabeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug
Being discontinued · February 20, 2026Decitabine, Injection, 50 mg (NDC 50742-430-01)
Ingenus Pharmaceuticals LLCDiscontinuation of the manufacture of the drug
Being discontinued · February 20, 2026 -
Docetaxel Being discontinued 2 products · updated February 20, 2026
Oncology
Product Availability Expected supply / notes Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16)
Ingenus Pharmaceuticals LLCA business decision was made to discontinue manufacture of the drug.
Being discontinued · February 20, 2026Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)
Ingenus Pharmaceuticals LLCA business decision was made to discontinue manufacture of the drug.
Being discontinued · February 20, 2026 -
Allopurinol Being discontinued 4 products · updated February 19, 2026
Oncology, Renal, Rheumatology
Product Availability Expected supply / notes Allopurinol, Tablet, 100 mg (NDC 0591-5543-10)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · February 19, 2026Allopurinol, Tablet, 300 mg (NDC 0591-5544-01)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · February 19, 2026Allopurinol, Tablet, 300 mg (NDC 0591-5544-05)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · February 19, 2026Allopurinol, Tablet, 100 mg (NDC 0591-5543-01)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · February 19, 2026 -
Cefepime Being discontinued 2 products · updated February 10, 2026
Anti-Infective
Product Availability Expected supply / notes Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug.
Being discontinued · February 10, 2026Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug.
Being discontinued · February 10, 2026 -
Chlorothiazide Being discontinued 1 product · updated February 10, 2026
Cardiovascular
Product Availability Expected supply / notes Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12)
Salix Pharmaceuticals, a division of Bausch Health US, LLC—
Being discontinued · February 10, 2026 -
Gemfibrozil Being discontinued 1 product · updated February 10, 2026
Endocrinology/Metabolism
Product Availability Expected supply / notes Lopid, Tablet, 600 mg (NDC 0071-0737-20)
Pfizer Inc.Discontinuation of the manufacture of the drug.
Being discontinued · February 10, 2026 -
Pindolol Being discontinued 2 products · updated January 30, 2026
Cardiovascular
Product Availability Expected supply / notes Pindolol, Tablet, 5 mg (NDC 57664-655-88)
Sun Pharmaceutical Industries, Inc.Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027
Being discontinued · January 30, 2026Pindolol, Tablet, 10 mg (NDC 57664-656-88)
Sun Pharmaceutical Industries, Inc.Discontinuation of the manufacture of the drug; Expiry date of last distributed batch October 2026
Being discontinued · January 30, 2026 -
Podofilox Being discontinued 1 product · updated January 28, 2026
Dermatology, Other
Product Availability Expected supply / notes Condylox , Topical Gel, 0.5% (NDC 0023-6118-03)
AbbVie Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 28, 2026 -
Benztropine Mesylate Being discontinued 1 product · updated January 27, 2026
Neurology
Product Availability Expected supply / notes Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug
Being discontinued · January 27, 2026 -
Fluvastatin Sodium Being discontinued 3 products · updated January 27, 2026
Cardiovascular
Product Availability Expected supply / notes Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31)
Sandoz Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 27, 2026Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31)
Sandoz Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 27, 2026Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01)
Sandoz Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 27, 2026 -
Maraviroc Being discontinued 1 product · updated January 20, 2026
Antiviral
Product Availability Expected supply / notes Selzentry, Solution, 20 mg/mL Oral Solution Kit | 230 mL Oral Solution per Bottle | 1 Bottle per Carton (NDC 49702-260-55)
ViiV Healthcare CompanyThe anticipated date that GSK will cease distribution of the product is approximately August 1, 2026.
Being discontinued · January 20, 2026 -
Piperacillin and Tazobactam Being discontinued 1 product · updated January 20, 2026
Anti-Infective
Product Availability Expected supply / notes Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug
Being discontinued · January 20, 2026 -
Riboflavin 5-Phosphate Being discontinued 1 product · updated January 20, 2026
Ophthalmology
Product Availability Expected supply / notes Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)
Glaukos CorporationDiscontinuing manufacture of the product as of July 2026.
Being discontinued · January 20, 2026 -
Adalimumab Being discontinued 6 products · updated January 13, 2026
Rheumatology
Product Availability Expected supply / notes Hyrimoz, Injection, Kit (NDC 61314-531-64)
Sandoz Inc.Equivalent Sandoz format is available.
Being discontinued · January 13, 2026Hyrimoz, Injection, Kit (NDC 61314-517-36)
Sandoz Inc.Equivalent Sandoz format is available.
Being discontinued · January 13, 2026Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68)
Sandoz Inc.Equivalent Sandoz format is available.
Being discontinued · January 13, 2026Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36)
Sandoz Inc.Equivalent Sandoz format is available.
Being discontinued · January 13, 2026Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64)
Sandoz Inc.Equivalent Sandoz format is available.
Being discontinued · January 13, 2026Simlandi, Kit, Kit (NDC 51759-523-21)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · November 13, 2025 -
Doxylamine Succinate and Pyridoxine Hydrochloride Being discontinued 1 product · updated January 12, 2026
Other
Product Availability Expected supply / notes Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01)
Mylan Pharmaceuticals Inc., a Viatris CompanyA business decision was made to discontinue manufacture of the drug.
Being discontinued · January 12, 2026 -
Neostigmine Methylsulfate Being discontinued 1 product · updated January 12, 2026
Analgesia/Addiction
Product Availability Expected supply / notes Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug
Being discontinued · January 12, 2026 -
Haloperidol Decanoate Being discontinued 2 products · updated January 9, 2026
Psychiatry
Product Availability Expected supply / notes Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug
Being discontinued · January 9, 2026Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug
Being discontinued · January 9, 2026 -
Imipenem and Cilastatin Being discontinued 1 product · updated January 8, 2026
Anti-Infective
Product Availability Expected supply / notes Primaxin, Injection, 500mg (NDC 0006-3516-59)
Merck Sharp & Dohme Corp.To be discontinued approximately 11/30/2026
Being discontinued · January 8, 2026 -
Diltiazem Hydrochloride Being discontinued 1 product · updated January 5, 2026
Cardiovascular
Product Availability Expected supply / notes Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03)
Hospira, Inc., a Pfizer CompanyDiscontinuation of the manufacture of the drug
Being discontinued · January 5, 2026 -
Hydroxychloroquine Sulfate Being discontinued 1 product · updated January 5, 2026
Anti-Infective, Other, Rheumatology
Product Availability Expected supply / notes Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 5, 2026 -
Sodium Oxybate Being discontinued 1 product · updated December 29, 2025
Psychiatry
Product Availability Expected supply / notes Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1)
Amneal PharmaceuticalsDiscontinuation of the manufacture of the drug
Being discontinued · December 29, 2025
Reading the list: a medicine stays on the FDA list while any of its products is short. "Available" next to a product means that particular strength or pack can currently be ordered. If your pharmacy cannot fill a prescription, ask the pharmacist or prescriber about another strength, form or an alternative — do not ration or stop a medicine on your own.
Source: FDA Drug Shortages Database, via openFDA. Updated here twice a day; last update November 1, 2026 02:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.